Montespace-AL Tablet SR is a once-daily, slow-release formulation designed to provide sustained relief from respiratory and allergic symptoms. This triple-ingredient combination contains Ambroxol 75mg, a mucolytic agent that helps to break down and clear mucus from the respiratory tract, Levocetirizine 5mg, a potent antihistamine that effectively alleviates pruritus, erythema, and edema associated with allergic reactions, and Montelukast 10mg, a leukotriene receptor antagonist that inhibits the production of pro-inflammatory mediators and reduces bronchospasm. The slow-release technology ensures a consistent and prolonged release of the active ingredients over 24 hours, providing a steady and effective treatment throughout the day. Montespace-AL Tablet SR is indicated for the treatment of chronic obstructive pulmonary disease (COPD), allergic rhinitis, and seasonal allergic rhinitis. It is also useful in the management of asthma, bronchitis, and bronchiectasis. The formulation is suitable for patients with mild to moderate respiratory and allergic symptoms, and is particularly beneficial for those who require long-term treatment.